121 related articles for article (PubMed ID: 7387759)
1. 3-Sulfamoylmethyl-1,2-benzisoxazole, a new type of anticonvulsant drug. Pharmacological profile.
Masuda Y; Karasawa T; Shiraishi Y; Hori M; Yoshida K; Shimizu M
Arzneimittelforschung; 1980; 30(3):477-83. PubMed ID: 7387759
[TBL] [Abstract][Full Text] [Related]
2. Denzimol, a new anticonvulsant drug. I. General anticonvulsant profile.
Graziani G; Tirone F; Barbadoro E; Testa R
Arzneimittelforschung; 1983; 33(8):1155-60. PubMed ID: 6685493
[TBL] [Abstract][Full Text] [Related]
3. Relationships between plasma concentrations of diphenylhydantoin, phenobarbital, carbamazepine, and 3-sulfamoylmethyl-1,2-benzisoxazole (AD-810), a new anticonvulsant agent, and their anticonvulsant or neurotoxic effects in experimental animals.
Masuda Y; Utsui Y; Shiraishi Y; Karasawa T; Yoshida K; Shimizu M
Epilepsia; 1979 Dec; 20(6):623-33. PubMed ID: 115675
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic tolerance of a new anticonvulsant agent (3-sulfamoylmethyl-1,2-benzisoxazole) compared to phenobarbital, diphenylhydantoin and carbamazepine in rats.
Masuda Y; Utsui Y; Shiraishi Y; Karasawa T; Yoshida K; Shimizu M
Arch Int Pharmacodyn Ther; 1979 Jul; 240(1):79-89. PubMed ID: 507999
[No Abstract] [Full Text] [Related]
5. 3-Sulfamoylmethyl-1,2-benzisoxazole, a new type of anticonvulsant drug. Electroencephalographic profile.
Ito T; Hori M; Masuda Y; Yoshida K; Shimizu M
Arzneimittelforschung; 1980; 30(4):603-9. PubMed ID: 7190399
[TBL] [Abstract][Full Text] [Related]
6. Influence of antazoline and ketotifen on the anticonvulsant activity of conventional antiepileptics against maximal electroshock in mice.
Swiader M; Wielosz M; Czuczwar SJ
Eur Neuropsychopharmacol; 2004 Aug; 14(4):307-18. PubMed ID: 15163441
[TBL] [Abstract][Full Text] [Related]
7. Effects of 3-sulfamoylmethyl-1,2-benzisoxazole (AD-810) and some antiepileptics on the kindled seizures in the neocortex, hippocampus and amygdala in rats.
Kamei C; Oka M; Masuda Y; Yoshida K; Shimizu M
Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):164-76. PubMed ID: 7224718
[TBL] [Abstract][Full Text] [Related]
8. Profile of SB-204269, a mechanistically novel anticonvulsant drug, in rat models of focal and generalized epileptic seizures.
Upton N; Blackburn TP; Campbell CA; Cooper D; Evans ML; Herdon HJ; King PD; Ray AM; Stean TO; Chan WN; Evans JM; Thompson M
Br J Pharmacol; 1997 Aug; 121(8):1679-86. PubMed ID: 9283703
[TBL] [Abstract][Full Text] [Related]
9. Anticonvulsant activities of nutmeg oil of Myristica fragrans.
Wahab A; Ul Haq R; Ahmed A; Khan RA; Raza M
Phytother Res; 2009 Feb; 23(2):153-8. PubMed ID: 19067329
[TBL] [Abstract][Full Text] [Related]
10. Imperatorin enhances the protective activity of conventional antiepileptic drugs against maximal electroshock-induced seizures in mice.
Luszczki JJ; Glowniak K; Czuczwar SJ
Eur J Pharmacol; 2007 Nov; 574(2-3):133-9. PubMed ID: 17651727
[TBL] [Abstract][Full Text] [Related]
11. Evidence against a significant implication of carbonic anhydrase inhibitory activity of zonisamide in its anticonvulsive effects.
Masuda Y; Noguchi H; Karasawa T
Arzneimittelforschung; 1994 Mar; 44(3):267-9. PubMed ID: 8192690
[TBL] [Abstract][Full Text] [Related]
12. Anticonvulsant properties of the novel nootropic agent nefiracetam in seizure models of mice and rats.
Kitano Y; Komiyama C; Makino M; Takasuna K; Takazawa A; Sakurada S
Epilepsia; 2005 Jun; 46(6):811-8. PubMed ID: 15946322
[TBL] [Abstract][Full Text] [Related]
13. Anticonvulsant effects of phencynonate hydrochloride and other anticholinergic drugs in soman poisoning: neurochemical mechanisms.
Wang YA; Zhou WX; Li JX; Liu YQ; Yue YJ; Zheng JQ; Liu KL; Ruan JX
Life Sci; 2005 Nov; 78(2):210-23. PubMed ID: 16154160
[TBL] [Abstract][Full Text] [Related]
14. An experimental evaluation of anticonvulsant activity of Vitex-negundo.
Tandon VR; Gupta RK
Indian J Physiol Pharmacol; 2005 Apr; 49(2):199-205. PubMed ID: 16170989
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of anticonvulsant and analgesic effects of benzyl- and benzhydryl ureides.
Librowski T; Kubacka M; Meusel M; Scolari S; Müller CE; Gütschow M
Eur J Pharmacol; 2007 Mar; 559(2-3):138-49. PubMed ID: 17250826
[TBL] [Abstract][Full Text] [Related]
16. Influence of chronic treatment with H1 receptor antagonists on the anticonvulsant activity of antiepileptic drugs.
Swiader M; Chwalczuk K; Wielosz M; Czuczwar SJ
Pol J Pharmacol; 2001; 53(1):93-6. PubMed ID: 11785920
[TBL] [Abstract][Full Text] [Related]
17. Comparative assessment of the anticonvulsant activity of some benzodiazepines, phenobarbitone and diphenylhydantoin against maximal electroshock seizures in rats: a time-distribution study.
Banerjee U; Yeoh PN
Med Biol; 1981 Aug; 59(4):253-8. PubMed ID: 6121957
[TBL] [Abstract][Full Text] [Related]
18. Preliminary evaluation of the anticonvulsant activity of a valproic acid analog: N-(2-propylpentanoyl) urea.
Tantisira B; Tantisira MH; Patarapanich C; Sooksawate T; Chunngam T
Res Commun Mol Pathol Pharmacol; 1997 Aug; 97(2):151-64. PubMed ID: 9344228
[TBL] [Abstract][Full Text] [Related]
19. Anticonvulsant drug effects in the direct cortical ramp-stimulation model in rats: comparison with conventional seizure models.
Krupp E; Löscher W
J Pharmacol Exp Ther; 1998 Jun; 285(3):1137-49. PubMed ID: 9618416
[TBL] [Abstract][Full Text] [Related]
20. Anticonvulsant and sodium channel-blocking properties of novel 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide derivatives.
Benes J; Parada A; Figueiredo AA; Alves PC; Freitas AP; Learmonth DA; Cunha RA; Garrett J; Soares-da-Silva P
J Med Chem; 1999 Jul; 42(14):2582-7. PubMed ID: 10411478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
